Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Europe Finance Weekly.

Amtech Software Announces Strategic Growth Investment from Vista Equity Partners
Amtech Software, a leading provider of enterprise software for the packaging industry, today announced a strategic growth investment from Vista Equity Partners (“Vista”), a global technology investor that specializes in enterprise software. The...

RIS Rx Announces Growth Investment from Summit Partners to Combat Revenue Leakage in Pharma Patient Affordability Programs
RIS Rx, a healthcare technology company pioneering solutions to reduce revenue leakage in pharmaceutical gross-to-net spread, today announced a significant growth investment from Summit Partners. This partnership will support RIS Rx’s continued...

Bennett Blau Joins Evercore as Senior Managing Director in the Healthcare Investment Banking Group
Evercore (NYSE: EVR) announced today that Bennett Blau has joined the firm as a senior managing director in the healthcare investment banking group, where he will focus on the medical technology sector. He will be based in San Francisco. Naveen...

ODYSIGHT.AI is strengthening its European Presence to Accelerate Industry 4.0: received Initial Order from Leading EU Player for AI-Driven industrial predictive health monitoring solutions"
OMER, Israel, June 16, 2025 (GLOBE NEWSWIRE) -- Odysight.AI Inc. (Nasdaq: ODYS), a pioneering developer of AI systems for Predictive Maintenance (PdM) and Condition-Based Monitoring (CBM), is pleased to announce the receipt of an initial order for...

X4 Pharmaceuticals Presents Positive Phase 2 Chronic Neutropenia Trial Data in Poster Presentations at the 30th Annual Congress of the European Hematology Association (EHA)
Poster #1654 highlights clinically meaningful and durable increases in circulating neutrophils observed with mavorixafor treatment +/- G-CSF over 6-month study Poster #1669 highlights findings that investigators were willing and able to reduce...

Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025
TNX-102 SL is a sublingual formulation of cyclobenzaprine designed for transmucosal delivery and durable activity in treating fibromyalgia: FDA PDUFA goal date of August 15, 2025 TNX-102 SL demonstrated statistically significant improvement in the...

Enphase Energy Rolls Out IQ Battery 5P with FlexPhase, Delivering Three-Phase Backup Across More European Countries
FREMONT, Calif., June 16, 2025 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the world's leading supplier of microinverter-based solar and battery systems, today announced the launch of its most...

KalVista Pharmaceuticals Presents New Data at the European Academy of Allergy and Clinical Immunology Congress 2025 on the Efficacy of Sebetralstat for the On-demand Treatment of HAE Attacks Among Patients Receiving Long-Term Prophylaxis
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the presentation of new data at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025 in Glasgow, United Kingdom that underscores the critical role of effective...

Coda Octopus Group Reports Fiscal Second Quarter 2025 Financial Results
ORLANDO, FL, June 16, 2025 (GLOBE NEWSWIRE) -- Coda Octopus Group, Inc. (“CODA” or the “Company”) (Nasdaq: CODA) a global market leader in real-time 4D/5D/6D imaging sonar technology for real-time subsea intelligence and cutting-edge diving...

Global Actigraphy Devices Market Analysis 2025 – Insights for Long-Term Investment & Planning
The Business Research Company's Actigraphy Devices Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 16, 2025 /EINPresswire.com/ -- What Does The Data On The Actigraphy...

Ocugen, Inc. Announces U.S. FDA Clearance of Investigational New Drug Amendment to Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial of OCU410ST—Modifier Gene Therapy Candidate for Stargardt Disease
MALVERN, Pa., June 16, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the U.S. Food and Drug Administration (FDA) has...

Fabry Disease Market Analysis 2025 – Insights For Long-Term Investment & Planning
The Business Research Company's Fabry Disease Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, June 16, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest...

AVEROA receives European marketing authorization for XOANACYL®, an Oral Therapy for Chronic Kidney Disease (CKD)
XOANACYL is an oral therapy designed to address critical challenges in CKD, including Iron deficiency and hyperphosphatemia Averoa submitted XOANACYL for UK approval via MHRA’s International Recognition Procedure AVEROA actively seeking strategic...

Sizzle Acquisition Corp. II Completes $230,000,000 Initial Public Offering
NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Sizzle Acquisition Corp. II (the “Company”) announced today the completion of its initial public offering of 23,000,000 units at a price of $10.00 per unit, resulting in gross proceeds of $230,000,000....

HAPPY FATHER’S DAY and $HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: OPOF, PRA, SWTX and FLS
NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPOF, PRA, SWTX on Behalf of Shareholders
NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders...

Oleochemicals Market is Forecasted to Reach USD 56.9 Billion by 2035 | Fact.MR
Analysis of Oleochemicals Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea ROCKVILLE , MD, UNITED STATES, June 17, 2025 /EINPresswire.com/ -- The global oleochemicals...

Deepening Trade Relations and Entrepreneurial Collaboration through the 3rd EU–African SME Summit In Johannesburg
The summit aims to catalyse long-term cooperation, especially in the context of the AfCFTA and EU Global Gateway JOHANNESBURG, GAUTENG, SOUTH AFRICA, June 15, 2025 /EINPresswire.com/ -- Contact: tiekie@shiftimpact.africa |...

Intellia Therapeutics Announces Positive Three-Year Data from Phase 1 Trial of Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema (HAE) at the European Academy of Allergy and Clinical Immunology Congress
With up to three years of follow-up, a single dose of lonvo-z led to a 98% mean reduction in monthly HAE attack rate in all 10 patients All 10 patients were attack-free and treatment-free for a median of 23 months through the latest follow-up,...

Ukraine Calls for Increased Investment in Defense Industry
(MENAFN) Ukrainian Foreign Minister Andrii Sybiha on Friday made a strong appeal for increased global investment in Ukraine’s defense industry, highlighting the country's combat-hardened military and cutting-edge drone capabilities as assets that...